From July 1, 2021 to September 30, 2021, the company has repurchased 2,886,900 shares, representing 0.52% for CNY 29.81 million. With this, the company has completed the repurchase of 19,086,325 shares, representing 3.39% for CNY 184.47 million under the buyback announced on February 2, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.09 CNY | -7.46% | -14.58% | +17.42% |
08-12 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Tranche Update on Henan Lingrui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 2, 2021.